Patents by Inventor Niels Mork

Niels Mork has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF
    Publication number: 20120196889
    Abstract: The present invention relates to novel catecholamine derivatives of Formula I, to processes for their preparation, pharmaceutical compositions containing them and to their use in therapy.
    Type: Application
    Filed: February 24, 2010
    Publication date: August 2, 2012
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Mogens Larsen, Klaus Gundertofte, Morten Jorgensen, Jennifer Larsen, Niels Mork, HåKan Wikström
  • TREATMENT OF DYSKINESIA RELATED DISORDERS
    Publication number: 20120108624
    Abstract: Disclosed herein are methods of treating Parkinsons disease while maintaining a low dyskinesia induction profile and methods of reversing dyskinesias comprising administering a therapeutically effective amount of a compound of the invention. The present invention further relates to uses and pharmaceutical compositions of said compounds in the manufacture of medicaments in treating the same.
    Type: Application
    Filed: February 26, 2010
    Publication date: May 3, 2012
    Inventors: Håkan Wikström, Morten Jørgensen, Niels Mork, Jennifer Larsen, Lars Torup, Benny Bang-Andersen
  • METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20120077836
    Abstract: Disclosed are pharmaceutical compositions and methods for the administration of (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol or a pharmaceutically acceptable salt thereof and related compounds for the treatment of neurological disorder such as Parkinson's disease and restless leg syndrome.
    Type: Application
    Filed: February 26, 2010
    Publication date: March 29, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Håkan Wikström, Morten Jorgensen, Niels Mork, Jennifer Larsen, Benny Bang-Andersen, Thomas Nikolaj Sager, Ask Püschl, Lars Torup
  • Catecholamine derivatives and prodrugs thereof
    Patent number: 8129530
    Abstract: The present invention relates to novel catecholamine derivatives of Formula I, to processes for their preparation, pharmaceutical compositions containing them and to their use in therapy.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: March 6, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Morten Jorgensen, Benny Bang-Andersen, Ask Puschl, Niels Mork, Jennifer Larsen
  • 2,3-dihydroindole compounds
    Patent number: 7544685
    Abstract: The invention relates to compounds of the formula I wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: June 9, 2009
    Assignee: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Krestian Larsen, Niels Mørk
  • CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF
    Publication number: 20090124651
    Abstract: The present invention relates to novel catecholamine derivatives of Formula I, to processes for their preparation, pharmaceutical compositions containing them and to their use in therapy.
    Type: Application
    Filed: August 19, 2008
    Publication date: May 14, 2009
    Applicant: H. LUNDBECK A/S
    Inventors: Morten Jorgensen, Benny Bang- Andersen, Ask Puschl, Niels Mork, Jennifer Larsen, Hakan Vilhelm Wikstrom
  • CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF
    Publication number: 20090062324
    Abstract: The present invention relates to novel catecholamine derivatives of Formula I, to processes for their preparation, pharmaceutical compositions containing them and to their use in therapy.
    Type: Application
    Filed: August 19, 2008
    Publication date: March 5, 2009
    Applicant: H. Lundbeck A/S
    Inventors: Morten Jorgensen, Benny Bang- Andersen, Ask Puschl, Niels Mork, Jennifer Larsen
  • Novel 2,3-dihydroindole compounds
    Publication number: 20070043058
    Abstract: The invention relates to compounds of the formula I wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
    Type: Application
    Filed: August 15, 2006
    Publication date: February 22, 2007
    Inventors: Benny Bang-Andersen, Krestian Larsen, Niels Mork
  • 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenides
    Publication number: 20050171135
    Abstract: The present invention relates to a hydrohalogenide of 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 4, 2005
    Applicant: H. Lundbeck A/S
    Inventors: Niels Mork, Heidi Lopez de Diego, Ole Nielsen
  • 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine] hydrohalogenides
    Patent number: 6844352
    Abstract: The present invention relates to a hydrohalogenide of 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: January 18, 2005
    Assignee: H. Lundbeck A/S
    Inventors: Niels Mørk, Heidi Lopez de Diego, Ole Nielsen
  • 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4'-piperidine] hydrohalogenides
    Publication number: 20030055074
    Abstract: The present invention relates to a hydrohalogenide of 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Application
    Filed: October 15, 2002
    Publication date: March 20, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Niels Mork, Heidi Lopez de Diego, Ole Nielsen